サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1303361

微生物検査市場：製品別（機器、試薬）、用途別（化学・素材製造、臨床、エネルギー）、エンドユーザー別-2023～2030年の世界予測

Microbial Testing Market by Product (Instruments, Reagents), Application (Chemical & Material Manufacturing, Clinical, Energy), End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 199 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
微生物検査市場：製品別（機器、試薬）、用途別（化学・素材製造、臨床、エネルギー）、エンドユーザー別-2023～2030年の世界予測
出版日: 2023年06月12日
発行: 360iResearch
ページ情報: 英文 199 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

微生物検査の世界市場は、2023年に37億6,516万米ドル、CAGR14.68％で大きく成長し、2030年には驚異的な99億281万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の微生物検査市場を評価するために不可欠です。ビジネス戦略と製品満足度の主要指標を検証することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.微生物検査の世界市場規模および予測は？

2.予測期間中、世界の微生物検査市場を形成するCOVID-19の阻害要因と影響は？

3.微生物検査の世界市場において予測期間中に投資すべき製品/セグメント/用途/分野は？

4.微生物検査の世界市場における競争戦略は？

5.微生物検査の世界市場における技術動向と規制の枠組みは？

6.微生物検査の世界市場における主要ベンダーの市場シェアは？

7.微生物検査の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • さまざまな感染症の蔓延
      • 製薬調査の急増と微生物学的品質管理の重視
      • 食品および化粧品の安全基準の向上
    • 抑制要因
      • 微生物検査商品のリコールに関する懸念
    • 機会
      • 微生物検査技術のますます進歩
      • 飼料原料および最終飼料の微生物学的評価の重要性が高まる
    • 課題
      • 熟練した労働力の不足とプロセスに関連する高コスト
  • 市場動向
    • 南北アメリカにおける技術的に進歩した微生物検査の開発の増加に伴う資金の利用可能性
    • アジア太平洋地域では、検査済みで保証された食品や医薬品を採用する意識が高まり、食品感染症や感染症の蔓延が増加
    • 食品安全に関する厳格な規制基準と、EMEA地域における製薬産業の拡大
  • COVID-19の累積的な影響
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み
  • 顧客のカスタマイズ

第6章 微生物検査市場：製品別

  • イントロダクション
  • 機器
  • 試薬

第7章 微生物検査市場：用途別

  • イントロダクション
  • 化学・素材製造
  • 臨床
    • 血流感染症
    • 消化器疾患
    • 歯周病
    • 呼吸器疾患
    • 性感染症
    • 尿路感染症
  • エネルギー
  • 環境
  • 食品検査
  • 医薬品

第8章 微生物検査市場：エンドユーザー別

  • イントロダクション
  • 学術研究機関
  • 病院と診断センター
  • ラボサービスプロバイダー

第9章 南北アメリカの微生物検査市場

  • イントロダクション
  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の微生物検査市場

  • イントロダクション
  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの微生物検査市場

  • イントロダクション
  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ分析：主要企業別
    • 合併・買収
    • 契約、コラボレーション、パートナーシップ
    • 新製品発売と機能強化
    • 投資、資金調達
    • 受賞・表彰・拡大

第13章 掲載企業一覧

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. MICROBIAL TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. MICROBIAL TESTING MARKET SIZE, 2022 VS 2030
  • FIGURE 3. MICROBIAL TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 5. MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 6. MICROBIAL TESTING MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 7. MICROBIAL TESTING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. MICROBIAL TESTING MARKET DYNAMICS
  • FIGURE 9. MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. MICROBIAL TESTING MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS MICROBIAL TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES MICROBIAL TESTING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC MICROBIAL TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA MICROBIAL TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. MICROBIAL TESTING MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. MICROBIAL TESTING MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. MICROBIAL TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. MICROBIAL TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 5. MICROBIAL TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. MICROBIAL TESTING MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 8. MICROBIAL TESTING MARKET SIZE, BY CHEMICAL & MATERIAL MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 10. MICROBIAL TESTING MARKET SIZE, BY CLINICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. MICROBIAL TESTING MARKET SIZE, BY BLOODSTREAM INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. MICROBIAL TESTING MARKET SIZE, BY GASTROINTESTINAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. MICROBIAL TESTING MARKET SIZE, BY PERIODONTAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. MICROBIAL TESTING MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. MICROBIAL TESTING MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. MICROBIAL TESTING MARKET SIZE, BY URINARY TRACT INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. MICROBIAL TESTING MARKET SIZE, BY ENERGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. MICROBIAL TESTING MARKET SIZE, BY ENVIRONMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. MICROBIAL TESTING MARKET SIZE, BY FOOD TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. MICROBIAL TESTING MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. MICROBIAL TESTING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. MICROBIAL TESTING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. MICROBIAL TESTING MARKET SIZE, BY LAB SERVICE PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS MICROBIAL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES MICROBIAL TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC MICROBIAL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA MICROBIAL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. MICROBIAL TESTING MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 194. MICROBIAL TESTING MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 195. MICROBIAL TESTING MARKET LICENSE & PRICING
目次
Product Code: MRR-036C5CF3A80D

The Global Microbial Testing Market is forecasted to grow significantly, with a projected USD 3,765.16 million in 2023 at a CAGR of 14.68% and expected to reach a staggering USD 9,902.81 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Microbial Testing Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Microbial Testing Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Instruments and Reagents. The Reagents commanded largest market share of 46.23% in 2022, followed by Instruments.

Based on Application, market is studied across Chemical & Material Manufacturing, Clinical, Energy, Environment, Food Testing, and Pharmaceutical. The Clinical is further studied across Bloodstream Infections, Gastrointestinal Diseases, Periodontal Diseases, Respiratory Diseases, Sexually Transmitted Diseases, and Urinary Tract Infections. The Clinical commanded largest market share of 41.12% in 2022, followed by Pharmaceutical.

Based on End-User, market is studied across Academic & Research Institutes, Hospitals & Diagnostic Centers, and Lab Service Providers. The Lab Service Providers commanded largest market share of 49.23% in 2022, followed by Hospitals & Diagnostic Centers.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded largest market share of 39.68% in 2022, followed by Americas.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Microbial Testing Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Microbial Testing Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Microbial Testing Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Microbial Testing Market?

4. What is the competitive strategic window for opportunities in the Global Microbial Testing Market?

5. What are the technology trends and regulatory frameworks in the Global Microbial Testing Market?

6. What is the market share of the leading vendors in the Global Microbial Testing Market?

7. What modes and strategic moves are considered suitable for entering the Global Microbial Testing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Microbial Testing Market, by Product, 2022 vs 2030
  • 4.3. Microbial Testing Market, by Application, 2022 vs 2030
  • 4.4. Microbial Testing Market, by End-User, 2022 vs 2030
  • 4.5. Microbial Testing Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in the prevalence of various infectious diseases
      • 5.1.1.2. Surge in pharmaceutical research and focus on microbiological quality control
      • 5.1.1.3. Rising safety standards for food and cosmetic products
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns related to the recall of microbial testing instruments
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing advancements in microbial testing technologies
      • 5.1.3.2. Growing importance of microbiological evaluation of feed ingredients and finished feeds
    • 5.1.4. Challenges
      • 5.1.4.1. Shortage of skilled workforce and the high cost associated with the processes
  • 5.2. Market Trends
    • 5.2.1. Availability of funding with the increasing development of technologically advanced microbial testing in the Americas
    • 5.2.2. Rising prevalence of food infection and infectious diseases with increasing awareness to adopt tested and assured food and pharmaceutical products in Asia-Pacific region
    • 5.2.3. Strict regulatory standards for food safety coupled with the rising expansion of the pharmaceutical industry in the EMEA region
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Microbial Testing Market, by Product

  • 6.1. Introduction
  • 6.2. Instruments
  • 6.3. Reagents

7. Microbial Testing Market, by Application

  • 7.1. Introduction
  • 7.2. Chemical & Material Manufacturing
  • 7.3. Clinical
    • 7.3.1. Bloodstream Infections
    • 7.3.2. Gastrointestinal Diseases
    • 7.3.3. Periodontal Diseases
    • 7.3.4. Respiratory Diseases
    • 7.3.5. Sexually Transmitted Diseases
    • 7.3.6. Urinary Tract Infections
  • 7.4. Energy
  • 7.5. Environment
  • 7.6. Food Testing
  • 7.7. Pharmaceutical

8. Microbial Testing Market, by End-User

  • 8.1. Introduction
  • 8.2. Academic & Research Institutes
  • 8.3. Hospitals & Diagnostic Centers
  • 8.4. Lab Service Providers

9. Americas Microbial Testing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Microbial Testing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Microbial Testing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player
    • 12.3.1. Merger & Acquisition
      • 12.3.1.1. Thermo Fisher Scientific Inc. - Thermo Fisher Scientific Completed Acquisition of The Binding Site Group
      • 12.3.1.2. Acquisition Expanded Water Microbiology Testing Capabilities Labmate Online
      • 12.3.1.3. SGS Acquired Industry Lab in Romania
      • 12.3.1.4. NAMSA Acquires UK-Based Perfectus Biomed Group to Enhance Customized Microbiological Solutions
      • 12.3.1.5. Bio-Rad buys Curiosity Diagnostics for up to USD 170 million
      • 12.3.1.6. BioMerieux Acquired Antibiotic Susceptibility Test Firm Specific Diagnostics
    • 12.3.2. Agreement, Collaboration, & Partnership
      • 12.3.2.1. Nemera and Nelson Labs Europe strengthened partnership to offer integrated services to customer
      • 12.3.2.2. Beckman Coulter and MeMed to Expanded Access to Proven Host Immune Response Diagnostic Able to Distinguish Between Bacterial and Viral Infections
      • 12.3.2.3. AstraZeneca Partnered with LBT to automate pharma microbial QC
      • 12.3.2.4. FASTinov collaborated with Beckman Coulter Life Sciences to bring ultra-rapid 2h-AST disruptive technology to clinical microbiology laboratories
      • 12.3.2.5. Medical Genomics and UgenTec partnered to automate cannabis testing results, minimizing labor and inconsistencies
      • 12.3.2.6. BD, Accelerate Diagnostics Announced Global Commercial Collaboration
      • 12.3.2.7. bioMerieux Collaborated with FSSAI to Celebrate World Food Safety Day 2022
    • 12.3.3. New Product Launch & Enhancement
      • 12.3.3.1. Bruker Introduced New Mycobacteria and Fungi IVD Solutions for MALDI Biotyper, and a Novel LiquidArray Gastrointestinal Syndromic Panel
      • 12.3.3.2. MicroVal Approved Bio-Rad PCR Kit for Detection of STEC in Flour and Raw Dough
      • 12.3.3.3. Hardy Diagnostics Launched New Ready-To-Use Dehydrated Culture Plate
      • 12.3.3.4. Charles River launched Endosafe Nexus 200
      • 12.3.3.5. LuminUltra launched latest molecular diagnostic innovation with the GeneCount Corrosion Collection
      • 12.3.3.6. Thermo Fisher introduced new gastrointestinal bacteria detection panel
      • 12.3.3.7. Microgenetics developed rapid microbial test method with six-hour result time
      • 12.3.3.8. MilliporeSigma Launched Culture Media System For Microbiological Food Testing
      • 12.3.3.9. Thermo Fisher Scientific launched rapid environmental PCR testing solution that detects in-air SARS-CoV-2 pathogens
      • 12.3.3.10. BD Introduced Smart Connected Robotics to Automate Microbial Identification
    • 12.3.4. Investment & Funding
      • 12.3.4.1. MilliporeSigma Invested USD 286 Million in U.S. Drug Safety Testing Capacity
      • 12.3.4.2. MSU researcher received USD 769K grant to develop rapid test for foodborne pathogens - Department of Biosystems & Agricultural Engineering
      • 12.3.4.3. Biolog Announced New Leadership Team and Secures Major Investment to Drive Widespread Adoption of Industry-Leading Microbial Identification and Phenotypic Profiling Products
      • 12.3.4.4. EUR 22 million EU (USD 23.21) backing for Israeli microbiology diagnostic leader Pocared
    • 12.3.5. Award, Recognition, & Expansion
      • 12.3.5.1. Nelson Labs receives ASCA accreditation from FDA
      • 12.3.5.2. SGS's New Agri-Commodity and Food Testing Laboratory in Brazil Received ISO 17025 and AOAC International Accreditation
      • 12.3.5.3. Roche received US FDA Emergency Use Authorization for its high-throughput automated test to detect monkeypox virus
      • 12.3.5.4. ADM opened N. America microbiology lab
      • 12.3.5.5. Solvay opened a new microbiology lab for the energy sector in the UK
      • 12.3.5.6. PerkinElmer Expands Food Safety Testing Portfolio with AOAC Certified Microbial Count Plates

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing